Literature DB >> 21641594

Steroid hormone hypersensitivity: clinical presentation and management.

Alek M Itsekson1, Daniel S Seidman, Matityahu Zolti, Michael Alesker, Howard J A Carp.   

Abstract

Hypersensitivity to estrogens and progestogens is often undiagnosed. The condition has many manifestations, including premenstrual syndrome, dysmenorrhea, and impaired fertility. Diagnosis is confirmed by skin testing for inflammatory responses to small doses of the hormone, and desensitization with small doses of the hormone is the most appropriate form of management.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641594     DOI: 10.1016/j.fertnstert.2011.05.025

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Autoimmune progesterone dermatitis manifesting as generalized fixed drug eruption.

Authors:  Juan Eduardo Carrasco-Zuber; Sergio Álvarez-Véliz; Catherina Moll-Manzur; Sergio González-Bombardiere
Journal:  An Bras Dermatol       Date:  2018 Nov/Dec       Impact factor: 1.896

Review 2.  Sex hormone allergy: clinical aspects, causes and therapeutic strategies - Update and secondary publication.

Authors:  E Untersmayr; A N Jensen; K Walch
Journal:  World Allergy Organ J       Date:  2017-12-27       Impact factor: 4.084

3.  Safety and value of skin test to sex hormones and sex hormone sensitivity desensitization in women with premenstrual syndrome.

Authors:  Alek M Itsekson; Bomstein Yonit; Itsekson-Hayosh Ze'ev; Zolti Matitiyahu; Kivity Shmuel
Journal:  World Allergy Organ J       Date:  2019-06-08       Impact factor: 4.084

Review 4.  Immunomodulation of carcinogens-induced steroids-dependent human diseases.

Authors:  Andrew N Glushkov; Elena G Polenok
Journal:  Saudi J Biol Sci       Date:  2017-10-03       Impact factor: 4.219

Review 5.  Cyclic catamenial dermatoses.

Authors:  Trinh Hermanns-Lê; Jean-François Hermanns; Marianne Lesuisse; Gérald E Piérard
Journal:  Biomed Res Int       Date:  2013-10-02       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.